PLoS ONE 2011-01-01

Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines.

Ines Tagoug, Amélie Sauty De Chalon, Charles Dumontet

Index: PLoS ONE 6(7) , e22641, (2011)

Full Text: HTML

Abstract

Multiple myeloma (MM) is a B cell neoplasm characterized by bone marrow infiltration with malignant plasma cells. IGF-1 signalling has been explored as a therapeutic target in this disease. We analyzed the effect of the IKK2 inhibitor AS602868, in combination with a monoclonal antibody targeting IGF-1 receptor (anti-IGF-1R) in human MM cell lines. We found that anti-IGF-1R potentiated the apoptotic effect of AS602868 in LP1 and RPMI8226 MM cell lines which express high levels of IGF-1R. Anti-IGF-1R enhanced the inhibitory effect of AS602868 on NF-κB pathway signalling and potentiated the disruption of mitochondrial membrane potential caused by AS602868. These results support the role of IGF-1 signalling in MM and suggest that inhibition of this pathway could sensitize MM cells to NF-κB inhibitors.

Related Compounds

  • TPCA-1

Related Articles:

IKK2 inhibition using TPCA-1-loaded PLGA microparticles attenuates laser-induced choroidal neovascularization and macrophage recruitment.

2015-01-01

[PLoS ONE 10 , e0121185, (2015)]

Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.

2015-11-01

[Virology 485 , 340-54, (2015)]

Intestinal expression of Fas and Fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of Fas modulating intestinal TLR-mediated inflammation.

2014-12-15

[J. Immunol. 193(12) , 6103-13, (2014)]

Dehydrocrenatidine is a novel janus kinase inhibitor.

2015-04-01

[Mol. Pharmacol. 87(4) , 572-81, (2015)]

Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells.

2015-01-30

[FEBS Lett. 589(3) , 396-406, (2015)]

More Articles...